Asia Pacific Arterial Blood Gas Kits Market Forecast to 2031 - Regional Analysis - by Syringe Type (Luer Slip Syringe and Luer Lock Syringe), Type (Vented and Non-vented), Usage (Pre-set Plunger Mode and Manual Aspiration), Application [In Vitro Diagnosti

The Asia Pacific arterial blood gas kits market was valued at US$ 1,51,398.54 thousand in 2023 and is expected to reach US$ 2,92,048.26 thousand by 2031; it is estimated to register a CAGR of 8.6% from 2023 to 2031.

Surging Adoption of Point-of-Care Diagnostics in Emerging Countries Fuels Asia Pacific Arterial Blood Gas Kits Market

The inability to run rapid diagnoses is a significant cause of deaths resulting from various diseases in emerging countries. An effective diagnostic infrastructure requires stable electrical power, sophisticated instruments, expensive reagents, and highly trained professionals; thus, diagnoses in developing countries are often limited by the unavailability of these resources. Moreover, the existing diagnostic capabilities result in long assay times, rendering them unsuitable for settings with limited resource availability. Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Point-of-care arterial blood gas kits allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in emergency departments, or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid–base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to promptly initiate appropriate treatments, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios. The shift toward point-of-care diagnostics also drives technological advancements in arterial blood gas kits as manufacturers focus on developing compact, automated, and easy-to-use devices that deliver accurate and fast results. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly arterial blood gas kits is rising in developing countries, which is likely to create growth opportunities for the market in the coming years.

Asia Pacific Arterial Blood Gas Kits Market Overview

As per China Macro Economy Journal 2021, nearly 264 million people are aged 60 or above in China, accounting for 18.7% of its total population. The presence of a large geriatric population can be associated with an increased respiratory disease burden as the elderly population is prone to various health conditions. As per the Frontier Media Public Health report published in June 2022, the most recent national survey of COPD showed that China accounted for almost 25% of all COPD cases globally. Moreover, the prevalence of COPD increased by 67% in people aged 40 or older compared with the survey results from 10 years ago, taking the condition to epidemic status. The surging prevalence of respiratory diseases and the growing geriatric population fuel the arterial blood gas kits market in China. Furthermore, the geographic expansion of various companies from other countries is also likely to support market growth.

Asia Pacific Arterial Blood Gas Kits Market Revenue and Forecast to 2031 (US$ Thousand)

Asia Pacific Arterial Blood Gas Kits Market Segmentation

The Asia Pacific arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.

Based on syringe type, the Asia Pacific arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.

In terms of type, the Asia Pacific arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.

By usage, the Asia Pacific arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.

Based on application, the Asia Pacific arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.

In terms of needle gauge, the Asia Pacific arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.

Based on syringe volume, the Asia Pacific arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.

By end user, the Asia Pacific arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.

Based on country, the Asia Pacific arterial blood gas kits market is segmented into China, Japan, India, Australia, South Korea, Kazakhstan, and the Rest of Asia Pacific. China dominated the Asia Pacific arterial blood gas kits market share in 2023.

Radiometer Medical ApS, Vyaire Medical Inc, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), SARSTEDT AG & Co KG, Lepu Medical Technology Beijing Co Ltd, and Levram Lifesciences Pvt. Ltd. are among the leading companies operating in the Asia Pacific arterial blood gas kits market.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific arterial blood gas kits market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific arterial blood gas kits market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific arterial blood gas kits market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.